adenoviral PSA vaccine ETBX-071
Term · Oncology and biomedicine · MLC-T-ONC-009676
A cancer vaccine composed of a genetically engineered, replication-deficient adenovirus carrying the gene encoding human prostate-specific antigen (PSA), with potential immunostimulating and antineoplastic activities. Upon vaccination with the adenoviral-PSA vaccine ETBX-071, the adenovirus infects cells and expresses PSA. In turn, PSA activates the immune system and induces a cytotoxic T-lymphocyte (CTL) response against PSA-expressing tumor cells. PSA, a tumor associated antigen (TAA), is expressed by prostate epithelial cells and is overexpressed in prostate cancer.
| Identifier | MLC-T-ONC-009676 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Adenoviral PSA Prostate Cancer Vaccine ETBX-071 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-009676",
"term": "adenoviral PSA vaccine ETBX-071",
"field": "Oncology and biomedicine",
"definition": "A cancer vaccine composed of a genetically engineered, replication-deficient adenovirus carrying the gene encoding human prostate-specific antigen (PSA), with potential immunostimulating and antineoplastic activities. Upon vaccination with the adenoviral-PSA vaccine ETBX-071, the adenovirus infects cells and expresses PSA. In turn, PSA activates the immune system and induces a cytotoxic T-lymphocyte (CTL) response against PSA-expressing tumor cells. PSA, a tumor associated antigen (TAA), is expressed by prostate epithelial cells and is overexpressed in prostate cancer.",
"synonyms": [
"Adenoviral PSA Prostate Cancer Vaccine ETBX-071"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/adenoviral-psa-vaccine-etbx-071/"
}
Record 412 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.